Shire to buy rare-disease specialist NPS Pharmaceuticals for $5.2bn

NPS is known for its two new drugs – Gattex, treatment for short-bowel syndrome, and Natpara for hypoparathyroidism.



via IBTimes.co.uk : Articles by Jerin Mathew http://ift.tt/1y2hhL7 January 12, 2015 at 12:39PM http://ift.tt/eA8V8J